Current Neuropharmacology
Title: Foreword [Cannabinoid Special Issue (Guest Editor: Ruth A. Ross)]
Volume: 2 Issue: 1
Author(s): Ruth A. Ross
Affiliation:
Export Options
About this article
Cite this article as:
Ross A. Ruth, Foreword [Cannabinoid Special Issue (Guest Editor: Ruth A. Ross)], Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476873
DOI https://dx.doi.org/10.2174/1570159043476873 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
8
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patient-Controlled Analgesia
Current Drug Targets Melatonergic Drugs for Therapeutic Use in Insomnia and Sleep Disturbances of Mood Disorders
CNS & Neurological Disorders - Drug Targets Comparative Study of the Inhibition of E. coli and Murine Aspartate Transcarbamylase by Phenobarbital Analogues
Letters in Drug Design & Discovery An Outline of the Historical and Clinical Aspects of Catatonic Schizophrenia
Current Psychiatry Reviews Getting Rid of Intracellular Aβ - Loss of Cellular Degradation Leads to Transfer Between Connected Neurons
Current Pharmaceutical Design Mental Health Disorder Therapeutic Modalities Modified for the GMS
Current Psychiatry Reviews Proteomic Analysis of Plasma to Reveal the Impact of Short-Term Etanercept Therapy in Pediatric Patients with Enthesitis-Related Arthritis: A Case Report
Combinatorial Chemistry & High Throughput Screening The Role of Platelet/Lymphocyte Serotonin Transporter in Depression and Beyond
Current Drug Targets Cannabinoid Receptor Type 2 Activation Yields Delayed Tolerance to Focal Cerebral Ischemia
Current Neurovascular Research Alzheimer’s Disease and its Related Dementia Types: A Review on Their Management <i>Via</i> Nanotechnology Based Therapeutic Strategies
Current Alzheimer Research Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
Anti-Cancer Agents in Medicinal Chemistry Serotonin and Human Cognitive Performance
Current Pharmaceutical Design Analysis of the Drug Release Profiles from Formulations Based on Micro and Nano Systems
Current Analytical Chemistry Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
Current Gene Therapy Probable Novel PSEN1 Gln222Leu Mutation in a Chinese Family with Early-Onset Alzheimer's Disease
Current Alzheimer Research Meet Our Associate Editor
Current Alzheimer Research Role of Connexins and Pannexins in Ischemic Stroke
Current Medicinal Chemistry The Nature and Implications of Implicit Weight Bias
Current Psychiatry Reviews Schizophrenia: From Dopamine to Glutamate and Back
Current Medicinal Chemistry A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
Current Pharmaceutical Design